Dissection of the Gastrointestinal-mediated Glucose Disposal and Incretin Defect in Patients With Type 2 Diabetes

NCT02669524 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Type 2 Diabetes

Interventions

DRUG: LY2409021
DRUG: LY2409021 placebo
PROCEDURE: OGTT
PROCEDURE: IIGI
PROCEDURE: Standardised liquid meal

Sponsor

University Hospital, Gentofte, Copenhagen

Collaborators

[object Object]